Schedule 13G ownership disclosure

BIOCRYST PHARMACEUTICALS INC

Security class unavailable · CUSIP: 09058V103

Event date: 2021-01-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,844,000
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-21-000082
Form type
SC 13G
Filer
BIOCRYST PHARMACEUTICALS INC
CIK
CIK 882796
Filed
Jan 25, 2021
Reporting period
Jan 15, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub